News
News
- Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
07/23/2021 / 12:45 - GlobeNewswire - Major Shareholder Announcement
07/21/2021 / 18:58 - GlobeNewswire - Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
07/21/2021 / 13:15 - GlobeNewswire - Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2021
07/21/2021 / 12:31 - GlobeNewswire - BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
07/19/2021 / 14:00 - GlobeNewswire - Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation, Including for the Treatment of Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
06/22/2021 / 16:12 - GlobeNewswire - BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
06/18/2021 / 11:00 - GlobeNewswire - Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
06/10/2021 / 08:00 - GlobeNewswire - Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration
06/02/2021 / 14:00 - GlobeNewswire - Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
05/28/2021 / 21:45 - GlobeNewswire
Real-time